The Pillar Centre | The Mater Hospital

Inaugural IPOMS Webinar Launch
2021-03-23 18:00 - 20:30 UTC
The Irish Perioperative Medicine Society is delighted to present the Inaugural IPOMS Webinar Launch
IPOMS Flyer FINAL

Register for FREE here: https://registration.ipoms.org

2 CPD points awarded from the College of Anaesthesiologists of Ireland (CAI)

IES Annual Conference 2020
2020-10-27 - 2020-10-28 | The Pillar Centre, Mater Misericordiae University Hospital, Eccles St, Northside, Dublin 7, D07 R2WY, Ireland
IES Annual Conference 2020
Friday 27th – Saturday 28th October
www.irishendocrinesociety.com/
The Pillar Center for Transformative Healthcare is delighted the host the Irish Endocrine Society’s 44th Annual Meeting, which for the first time will be virtual. This year’s programme is more compact than usual but still includes invited local (Professor Donal O’ Gorman) and international speakers (Professors Helen Murphy and John Achermann), 14 oral research presentations, and for the first time a formal poster session dedicated to the best submitted case reports and case series/ audits. The meeting will be relevant to clinicians and scientists in the fields of Adult and Paediatric Endocrinology, and there will be opportunities to interact with sponsoring Pharma companies.

THE 2020 INNOVATION SPRINT
2020-10-12 00:00 - 2020-10-22 23:59
Missed our Innovation Sprint Presentation Webinar?
Team A Presentation: “Automated reporting system to provide PKU patients with their Phenylalanine (Phe) level results” https://vimeo.com/490651304

Team B Presentation: “Cast in a can –aerosolised fracture immobilisation device” https://vimeo.com/490690864

Team C Presentation: “Atomiser catheter for the “spray as you go” technique in awake fiberoptic intubation” https://vimeo.com/490661614

Team D Presentation: “Post-Operative Wound Management. A Step into the Future” https://vimeo.com/490653969
Missed our Introductory Webinar to the 2020 Innovation Sprint?
Prof Brendan Kinsley, Director Pillar Centre for Transformative Healthcare – Introduction to the Pillar Centre for Transformative Healthcare https://vimeo.com/user124607674/review/472641556/6a636312b7

Dr Grainne Cunniffe, Director Spinal Research, National Spinal Injuries Unit / Mater Misericordiae University Hosp. https://vimeo.com/user124607674/review/472641422/ef6fa2b340

Dr Ena Walsh, Technology Transfer Officer, NovaUCD – Importance of IP, Patents and Supports from NovaUCD https://vimeo.com/user124607674/review/472641219/1fb3fbc71b

Dr Zara Lonergan, Senior Commercialisation Expert, Enterprise Ireland – Enterprise Ireland Supports for Medtech: Commercialisation Grants https://vimeo.com/user124607674/review/472641946/8c223f2b40
Q & A Session 1
Dr Eoin O Cearbhaill, Associate Professor in Biomedical Engineering, UCD – Medtech Development Pathway https://vimeo.com/user124607674/review/472641350/6747b8eaa1
Mr Seamus Morris, Consultant Orthopaedic Spinal Surgeon, National Spinal Injuries Unit / Mater Misericordiae University Hosp – Lean Design Concepts for Medical Device Design https://vimeo.com/user124607674/review/472655489/042e974538
Q & A Session 2
https://vimeo.com/user124607674/review/472641832/34c35025a3

Virtual 8 week Medtech Development Programme

Identify a viable solution to an unmet clinical need
Utilise team-based development of ideas
Mentor-assisted team brainstorming
Establish feasibility for an enterprise ireland funding application

Free of charge to Hospital staff

Closing Date: Wed 21st October

Applications invited Wed 14th October

Frequently Asked Questions
Can I bring my own idea to the programme?Yes, participants are invited to get involved with or without any pre-existing idea. We envisage that each team will discuss and submit a number of ideas for initial review, at which point a panel of experts will evaluate and provide feedback on which idea they deem most suitable to work on for the duration of the programme. The skills learned during this development programme can then be applied by any individual to work independently on their ideas, or in future iterations of this innovation programme at future dates.Can I work with a team of colleagues?Yes, if you have a preference to work solely with a team of your colleagues please include that in your registration email to sprints@mater.ie. Otherwise, teams will be formed from participants registering individually.
What work load is anticipated over the 8 weeks?This will vary week to week and depend on the amount of work required to develop an idea through to the presentation and final application stage, but it is envisaged that it will require approximately 2 hours of work per week to brainstorm with your team or work independently to generate a team “elevator pitch” 5 minute presentation. Teamworking sessions can be scheduled by the appointed team lead to suit the team best.
What will be the end result of this programme?All participants who complete this programme will receive a certificate of completion from the Pillar Centre. It is anticipated that the ideas developed during the programme will be written up in an application form such as the Enterprise Ireland commercialisation feasibility funding (https://www.enterprise-ireland.com/en/funding-supports/Researcher/Funding-to-Commercialise-Research/Commercialisation-Fund-Programme-Commercial-Case-Feasibility-Grant.html​) to apply for funding to continue to develop the ideas towards commercialisation. Guidance will be provided by the programme organisers to select the appropriate funding application, or invention disclosure form to best suit the developed solution.
For more information please contact SPRINTS@MATER.IE
Supported by the Pillar Centre for Transformative Healthcare

VTE Dublin 2020
2020-10-02 | The Pillar Centre, Mater Misericordiae University Hospital, Eccles St, Northside, Dublin 7, D07 R2WY, Ireland
Diagnostic and therapeutic advances in venous thromboembolism (VTE)

Opening Address: Prof Fionnuala Ní Áinle, Consultant Haematologist, MMUH/Rotunda Hospitals

Session 1

Time
Talk
Presenter
About the Presenter

09:00-09:30
Direct thrombus imaging: the future looks bright
Dr Erik Klok
Dept of Thrombosis and Haemostasis, Leiden University Medical Centre, Leiden, The Netherland; visiting Professor, Center for Thrombosis and Hemostasis, Mainz, Germany

09:30-10:00
Enoxaparin for Primary Thromboprophylaxis in Symptomatic Ambulatory Patients With
COVID-19: the Randomized Controlled Trial OVID
Dr Stefano Barco
Staff Physician, Clinic of Angiology, Zurich, Switzerland

09:30-10:00
HYPATIA: a randomised controlled trial in pregnant women with antiphospholipid antibodies
Dr Karen Schrieber
Danish Hospital for Rheumatic disease in Sonderburg, Denmark

09:30-10:00
Coffee

09:30-10:00
The Patient Experience
Ms Ann-Marie O’ Neill
Thrombosis Ireland

Session 2

Time
Talk
Presenter
About the Presenter

11:30-12:00
Covid-19 coagulopathy and thrombosis: Novel prognostic and therapeutic opportunities: The COCOON study
Dr Barry Kevane
Consultant Haematologist, Mater Misericordiae University Hospital, Dublin

12:00-12:30
VTE & Immunothrombosis; Where do we go from here?
Professor Beverley Jane Hunt OBE
Professor of Thrombosis & Haemostasis at King’s College London; Consultant in the Departments of Haematology & Pathology at Guy’s & St Thomas NHS Foundation Trust; & Clinical Lead in Haematological Sciences at Viapath LLP

12:30-13:00
COVID-19: clinical pitfalls in the ICU
Prof Jan Beyer Westendorf
Head of Division “Thrombosis Research”, Medical Clinic III Dresden University Clinic

13:00-13:30
Dr Clive Kearon Memorial Lecture
Improving the diagnosis of pulmonary embolism in the emergency Department.
Dr Kerstin de Wit
Assistant Professor, Division of Emergency Medicine, Department of Medicine; Emergency Medicine and Thrombosis Physician, Hamilton Health Science, Ontario, Canada

13:30-14:00
Lunch

Session 3

Time
Talk
Presenter
About the Presenter

14.00-14:30
Anticoagulation for COVID-19
Dr Michelle Sholzberg
Division Head of Hematology-Oncology, Medical Director of the Coagulation Laboratory, Director of the Hematology-Oncology Clinical Research Group, St. Michael’s Hospital, Li Ka Shing Knowledge Institute, University of Toronto

14:30-15:00
Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism: The COBRRA study
Dr. Lana Castellucci
Assistant Professor, Division of Hematology, Department of Medicine, University of Ottawa. Scientist, Clinical Epidemiology Program, Ottawa Hospital Research Institute

15:00-15:30
The Pilot PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity (PARTUM)
Dr Leslie Skeith
Division of Hematology Department of Medicine, University of Calgary , Calgary, Canada, CanVECTOR Research Network

15:30-16:00
VTE in COVID-19: the Boston experience
Dr Rachel Rosovsky
Director, Thrombosis Research, Division of Hematology, Massachusetts General Hospital, Co-Chair of MGH’s Thrombosis Committee and Assistant Professor of Medicine, Harvard Medical School

16:30-16:45
Close

Programme OutlineClick to download the programmeDownload

This meeting is kindly supported by the Mater Postgraduate centre with unrestricted educational support from Leo Pharma, Sanofi, BMS and Bayer
